A., Casey, R
For weight management , if a GLP-1 agonist was prescribed primarily for obesity, alternatives include: Orlistat , a lipase inhibitor that reduces fat absorption Structured lifestyle interventions including dietary modification, increased physical activity, and behavioural therapy Bariatric surgery for patients meeting NICE criteria (typically BMI 40 kg/m or 35 kg/m with obesity-related conditions) [2] Next steps following an allergic reaction should include: Documentation of the allergy in medical records and prescription systems Provision of written information about the reaction for the patient Discussion of alternative treatment options tailored to individual clinical needs Regular follow-up to monitor diabetes control and adjust therapy as needed Consideration of referral to specialist services (endocrinology, allergy, or weight management) where appropriate Reporting the suspected adverse reaction to the MHRA via the Yellow Card Scheme (yellowcard.mhra.gov.uk) Patients should be reassured that effective alternatives exist and that an allergic reaction to one medication does not preclude successful management of their condition with other therapies
Tirzepatide was found to be effective in promoting insulin secretion dependent on glucose through GIPR and GLP1R activation in both in vivo and in vitro models
[DOI] [PMC free article] [PubMed] [Google Scholar] 20.Rubino D., Abrahamsson N., Davies M., Hesse D., Greenway F.L., Jensen C., Lingvay I., Mosenzon O., Rosenstock J., Rubio M.A., et al
